Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.
By G. Amminger, M. Schäfer, K. Papageorgiou, C. Klier, S. Cotton, S. Harrigan, A. Mackinnon, Patrick D. McGorry, G. Berger. Archives of General Psychiatry, 2010
880 citations recorded by the source corpus.
Subfields: Nutrition and Dietetics, Psychiatry and Mental health, Sociology and Political Science
View Paper: https://www.semanticscholar.org/paper/54dceedd965e85f5cb37087c27de5509d26ed378
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Sociology and Political Science
Citations in the corpus
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders (2016, background): “Fish oil supplementation showed benefit for people with an at-risk mental state in a single study (Amminger et al., 2010), but this has yet to be replicated.”
- Rebooting Psychotherapy Research and Practice to Reduce the Burden of Mental Illness (2011, background): “More recently, a randomized and placebo controlled trial suggests therapeutic effects of fatty acid supplements on psychoses (Amminger et al., 2010).”